Edition:
United States

Health News

FDA approves Celgene's bone marrow cancer treatment

The U.S. Food and Drug Administration on Friday approved Celgene Corp's Inrebic to treat certain rare forms of bone marrow cancer called myelofibrosis, making it the second approved drug to treat the disease.

Health Reform Watch